Care processes in people in remission from type 2 diabetes: A cohort study using the National Diabetes Audit.
remission
routine care
type 2 diabetes
Journal
Diabetic medicine : a journal of the British Diabetic Association
ISSN: 1464-5491
Titre abrégé: Diabet Med
Pays: England
ID NLM: 8500858
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
revised:
28
10
2022
received:
13
06
2022
accepted:
20
11
2022
pubmed:
29
11
2022
medline:
11
2
2023
entrez:
28
11
2022
Statut:
ppublish
Résumé
People with type 2 diabetes can enter remission but may relapse or develop legacy complications. This analysis assesses whether people with remission from type 2 diabetes continue receiving annual care processes recommended in national guidelines and the potential impacts of formal recognition of remission. People with type 2 diabetes with and without formal recognition (diagnostic code) of remission, and with and without evidence of remission (HbA Of the 2,822,145 people with type 2 diabetes in the cohort, 16,460 (0.58%) were coded with remission in the 2018/19 NDA. After adjustment for age, sex, socioeconomic deprivation and ethnicity, people coded with remission were less likely to receive each care process than those without such coding irrespective of HbA People coded with remission of type 2 diabetes were less likely to receive diabetes care processes than those without such coding. People with evidence of remission had only a slightly reduced likelihood of receiving care processes. Formal recognition of remission may affect the provision or uptake of care processes.
Identifiants
pubmed: 36440921
doi: 10.1111/dme.15016
pmc: PMC10108144
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e15016Subventions
Organisme : NHS England and NHS Improvement
Organisme : Diabetes UK
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RE/18/6/34217
Pays : United Kingdom
Informations de copyright
© 2022 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.
Références
JAMA. 2014 Jun 11;311(22):2297-304
pubmed: 24915261
Diabetes Care. 2016 Jun;39(6):924-33
pubmed: 27222550
BMJ. 2014 Jan 24;348:f7450
pubmed: 24464277
Lancet. 2018 Feb 10;391(10120):541-551
pubmed: 29221645
Diabet Med. 2021 Sep;38(9):e14616
pubmed: 34062007
Diabetes Care. 2022 May 1;45(5):1151-1161
pubmed: 35320360
Diabet Med. 2023 Mar;40(3):e15016
pubmed: 36440921
Diabetologia. 2016 May;59(5):945-53
pubmed: 26983924
N Engl J Med. 2012 Apr 26;366(17):1577-85
pubmed: 22449317
JAMA. 2012 Dec 19;308(23):2489-96
pubmed: 23288372
Lancet Diabetes Endocrinol. 2019 May;7(5):344-355
pubmed: 30852132